
|
www.aurobindo.com |
|

|
Hyderabad,
8th November, 2004 |
|
|
AUROBINDO IN FORBES LIST
BEST UNDER A BILLION - ASIA'S RISING COMPANIES |
| |
|
Aurobindo Pharma Ltd is pleased to inform that
The “Forbes Magazine” has listed
Aurobindo among the “Best under a Billion -
Asia’s Rising Companies” in its latest issue
dated November 1, 2004. The list covers the 100
best Smaller-Size enterprises in both
Asia-Pacific and Europe. |
|
The magazine informs that a database of 2,600
publicly traded Asian companies, which had under
US$ 1Billion year revenue and five-year returns
on capital of at least 5 percent, was screened
to prepare the list. Sustained gains in sales
and returns were considered for ranking. It also
looked for companies with a track record of
rewarding their shareholders. |
|
Aurobindo Pharma is happy to be listed by the
magazine and is confident that this recognition
shall further fuel the company to excel. |
|
About Aurobindo Pharma Ltd |
|
Aurobindo Pharma Limited based at Hyderabad,
India manufactures Generic pharmaceuticals and
Active Pharmaceutical Ingredients. The company’s
robust product portfolio is spread over 6 major
product areas encompassing (Antibiotics,
Anti-Retro Virals, CVS, CNS,
Gastroenterologicals, and Anti-Allergics) with
around 65 API’s in the Non-Antibiotics and over
55 API’s in the Antibiotic segment. The
Company is selling its products in over 100
countries. |
|
|
|
|
|